About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, March 6th, 2017

The QualityStocks
Daily Stock List


Major League Football, Inc. (MLFB)

TopPennyStockMovers, Stock News Now, and SmallCapVoice reported previously on Major League Football, Inc. (MLFB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Major League Football, Inc. is a new, professional spring-football league. The Company’s shares began trading on the OTC Markets Group’s OTCQB on September 16, 2015. The Company beforehand went by the name Universal Capital Management, Inc. It changed its corporate name to Major League Football, Inc. in November of 2014. Major League Football is based in Lakewood Ranch, Florida.

Major League Football’s plan is to establish franchises and provide fans with professional football in the National Football League off-seasons. Its dedication is to creating a ground-breaking, accessible, and fan-owned game. Major League Football has targeted eight cities, presently without a professional football franchise, to host a MLFB franchise, its players, coaching staff, as well as support organization.

The teams of the league will focus on emerging markets in select U.S. cities to grow the overall popularity of the sport. Major League Football is considering more than 14 new markets as potential cities the league will further review to set the number of teams in its inaugural season.

Major League Football announced in September of 2015 that it began finalizing potential host venues across the country to establish cities that will become the inaugural season team sites. The Company confirmed its plans based on the earlier round of financing acquired by the league and additional investor interest.

Major League Football said that it will review the venues in cities earlier announced, evaluate fan appeal, local business support and other criteria. This is to reconfirm cities and their venues best suited for the league's inaugural kick off.

The new, professional spring football league is targeted to launch in April of this year. In 2016, Major League Football announced the appointment of its President, Mr. Wesley S. Chandler to its Board of Directors. Mr. Chandler took on the role of President of Major League Football in July of 2014.

This past October, Major League Football announced a Letter of Intent (LOI) for a stadium services and operations agreement with The Parker Company, LLC., an international hospitality and sports venue procurement firm headquartered in Miami, Florida.

At first, the Parker Company team will concentrate on finalizing MLFB stadium selection and lease agreements in eight emerging football markets across the United States for the 2017 spring football season, develop fresh branding concepts unique to MLFB and its community-centric message, and manage the venue and game-day operations. This includes stadium and arena procurement services.

Major League Football, Inc. (MLFB), closed Monday's trading session at $0.09, up 7.14%, on 184,398 volume with 22 trades. The average volume for the last 60 days is 144,680 and the stock's 52-week low/high is $0.0675/$1.17.

Zoom Telephonics, Inc. (ZMTP)

Marketbeat, Wall Street Mover, OtcWizard, SmallCapVoice, FeedBlitz, and OTC Picks reported on Zoom Telephonics, Inc. (ZMTP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Zoom Telephonics, Inc. is a top manufacturer of cable modems and other communications products. The Company designs, produces, markets, and supports cable modems and other communications products under the Zoom, Hayes®, and Global Village® brands. Established in 1977, Zoom Telephonics is based in Boston, Massachusetts and the Company lists on the OTCQB.

Zoom’s products include cable modems & gateways, dial-up modems, mobile broadband modems and routers, wireless networking products, ADSL gateways, Bluetooth wireless products, wireless keyboards, and ZoomGuard wireless sensors & controls.

Moreover, products include asymmetric digital subscriber line modems, wireless local area networking products, Voice Over IP products (VoIP), wired networking equipment, dialers and related telephony products, wireless sensors and controls, phone jacks and AC power adapters, and language-related specifics.

Zoom Telephonics has achieved PTCRB and FCC 15B certification for its model 4575 14.4 Mbps cellular modem with GPS. This is the first of the new ZoomCell™ line of cellular modems for AT&T and other GSM services. Zoom is offering models with top speeds of 3.6 Mbps, 14.4 Mbps, and 100 Mbps (LTE).

In May 2015, the Company signed an exclusive license agreement with Motorola Mobility LLC. The license agreement is for the Motorola brand in connection with consumer cable modem products. This includes cable modem bridges, cable modem/routers, and cable set-top boxes containing cable modems, for the U.S. and Canada. The agreement began on January 1, 2016 and it runs through December 31, 2020.

Zoom Telephonics has its new line of Motorola brand cable modems. Effective January 1, 2016, the Company, via its MTRLC division, commenced its exclusive 5-year license for producing Motorola brand cable modems and gateways. The first three products in the new Motorola line are the MB7220 8x4 cable modem, the MB7420 16x4 cable modem, and the MG7310 8x4 N300 Wi-Fi(R) cable gateway.

Last week, Zoom Telephonics reported financial results for Q4 and year ended December 31, 2016. Zoom reported net sales of $5.1 million for Q4 ended December 31, 2016. This represents an increase of 191 percent from $1.8 million for Q4 ended December 31, 2015.

The Company reported a net loss of $990,000 or $0.07 per share for Q4 2016 versus a net loss of $724,000 or $0.05 per share for Q4 2015. Gross profit was $1.4 million or 27.3 percent of net sales in Q4 2016, versus $0.5 million or 27.8 percent of net sales in Q4 2015. The increase in gross profit in Q4 2016 was because of greater sales, especially for Motorola brand cable modems and gateways.

Zoom Telephonics, Inc. (ZMTP), closed Monday's trading session at $1.80, up 5.88%, on 3,440 volume with 9 trades. The average volume for the last 60 days is 5,573 and the stock's 52-week low/high is $1.46/$3.20.

Zynex, Inc. (ZYXI)

BUYINS.NET, TaglichBrothers, Zacks, SmarTrend Newsletters, FeedBlitz, FNNO Newsletters, Daily Markets, and SmallCapVoice reported previously on Zynex, Inc. (ZYXI), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company with its corporate headquarters in Lone Tree, Colorado. The Company specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. In addition, Zynex is developing a new blood volume monitor for use in hospitals and surgery centers.  Zynex’s shares trade on the OTC Markets Group’s OTCQB.

The Company markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. Additionally, it markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients.

Zynex’s product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold around the world.  Zynex engineers, manufactures, markets and sells its own design of medical devices in three subsidiaries.

Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets.

In March of 2015, Zynex announced that it submitted a Pre-Submission application to the FDA for its non-invasive Blood Volume Monitor, CM-1500. Zynex’s belief is that this will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.

In September of 2015, Zynex announced that its wholly-owned subsidiary, Zynex Monitoring Solutions, filed an application with the FDA pursuant to Section 510(k) of the Food, Drug and Cosmetic Act for clearance of its new CM-1500 monitoring device.

In late December 2016, Zynex announced that it was invited to participate in a new US Army Hemorrhaging Detection Project.

Mr. Thomas Sandgaard, Chief Executive Officer of Zynex, said in December, "On another note we are proud to announce that Zynex has been invited to participate in a new US Army Hemorrhaging Detection Project. We believe we have very valuable information to share as well as a product that not only is substantially fully developed but will be able to serve an obvious need within the US Army. Our Blood Volume Monitor is still awaiting market clearance from the FDA."

Zynex, Inc. (ZYXI), closed Monday's trading session at $0.328, up 2.50%, on 24,377 volume with 8 trades. The average volume for the last 60 days is 9,092 and the stock's 52-week low/high is $0.102/$0.36.

Sterling Group Ventures, Inc. (SGGV)

PennyOmega reported on Sterling Group Ventures, Inc. (SGGV), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Sterling Group Ventures, Inc. is a natural resource company which established in 1994.  It chiefly involves in the search, exploration, and development of phosphate and related minerals. The Company has interests in the Gaoping phosphate mine in Tanjiachang village, Chenxi County, Hunan province, China. Sterling Group Ventures is based in Vancouver, British Columbia.

Sterling signed two agreements with Chenxi County Hongyu Mining Co. Ltd. (Hongyu) and its shareholders with regard to the Gaoping phosphate mine (GP Property) and other phosphate resources in Hunan Province. Hongyu is a Chinese private mining company with connections and resources in Hunan. Hongyu’s interest is in exploring, developing, as well as expanding its phosphate business.

Sterling Group Ventures, via its wholly-owned subsidiary, Silver Castle Investments Ltd., signed a Letter of Intent (LOI) with Chenxi County Merchants Bureau. This is for a larger exploration area named the Tanjiachang Village Phosphate Deposit.

Hongyu’s mining permit allows initial production of up to 100,000 tonnes of phosphate ore each year. The Inferred Resource is 2,190,000 tonnes of 22.58 percent P2O5 within the mining permit. Sterling has commenced production operations on its Gaoping Phosphate Project (GP Property).

Regarding the GP Phosphate Project, it is in Hunan Province in South Eastern China about 250 kilometers west of the Provincial Capital of Changsha and 120 kilometers’ northeast of the regional center of Huaihua city and 38 kilometers east of the County seat at Chenx. The GP Phosphate Property is a sedimentary deposit. It occurs at the Jinjiadong Formation of Upper Sinian. The Chinese government approved the acquisition of Hongyu by Sterling's Silver Castle Investments, on May 16, 2011.

In November 2016, Sterling Group Ventures reported that on November 11, 2016, it signed a definitive share exchange agreement with Euroclub Holding Ltd. Thus, Euroclub will become a subsidiary of Sterling Group Ventures with business partners operating in Brazil, Russia, India, China, and Europe. The company's online gaming platform is presently being launched nationwide in India and China.

Euroclub is a well-established online gaming company. It provides a B2B (Business-to-Business) and B2C (Business-to-Consumer) multi-gaming platform under the MOJO brand name with a complete family of social and real money gaming products.

Last month, Sterling Group Ventures announced that Mojo Games, Inc., its subsidiary, launched Mercury Gaming Solutions as the initial network partner in the new India Poker Network. The Joint Venture Partnership between Mercury Gaming Solutions, a subsidiary of The Essel Group, and Mojo Games was established as part of an online strategy to build a nationwide poker network in India.

The Joint Venture is a 50/50 split in ownership and profits for the network whereby Mojo Games supplies iGaming technology, ecommerce, back office and marketing support. The Essel Group is a recognized Indian Conglomerate having a varied business presence across numerous industries.

Sterling Group Ventures, Inc. (SGGV), closed Monday's trading session at $0.145, up 2.11%, on 45,000 volume with 1 trade. The average volume for the last 60 days is 62,955 and the stock's 52-week low/high is $0.0125/$0.18.

ABCO Energy, Inc. (ABCE)

Penny Stocks On Steroids, POSstocks, and PennyStock Tweets reported earlier on ABCO Energy, Inc. (ABCE), and we report on the Company today, here at the QualityStocks Daily Newsletter.

ABCO Energy, Inc. is an Arizona licensed contractor for the sales and installation of Photovoltaic Solar Systems, Solar Street Lighting, and the installation of LED and energy conservation lighting systems in its marketplaces. The Company provides products and services for residential, commercial, government and non-profit entities in all its markets. Founded in 2008, ABCO Energy is based in Tucson, Arizona and the Company lists on the OTC Markets Group’s OTCQB.

ABCO Solar is a partner with ABCO Energy. ABCO Solar is a full-service, licensed electrical contractor. It assists its customers with every stage of their solar panel installation. This includes size determination, financing options, tax, and utility incentives.

ABCO Energy sells and installs solar photovoltaic electric systems, which enable customers to produce power on their residence or business property. Furthermore, ABCO Energy sells and installs energy efficient lighting products, solar powered street lights, as well as lighting accessories to commercial and residential customers. Additionally, the Company provides solar leasing and long term financing programs to its customers and other marketing and installation organizations.

ABCO Energy announced in December of 2015, the completion of a 70,560 Watt DC voltage first phase, and another smaller project of 22,500 Watt DC of its backlogged commercial solar projects. The system will provide shaded parking for up to 48 recreational vehicles.

ABCO Energy completed all solar system components, system design, permitting, and electrical interconnection to set the system online in December 2015. All steel components were built by Park N Shade steel contractors of Tucson, Arizona.

ABCO Energy announced in April 2016 the construction launch of a 68.04 Kilowatt project in the Phoenix Metropolitan area. The project is part of a chain of five projects comprising parking structures with solar on the roofs and the parking of Recreational Vehicles (RVs) underneath. This project will provide electricity for the whole storage center.

Regarding Photovoltaic Residential Solar Systems, an ABCO Energy Solar System includes personalized system design; equipment and connectivity; drawings and permitting with all local jurisdictions. It also includes professional installation; system testing; and any required local government and utility company inspections.

Concerning Commercial Solar, when a client purchases an ABCO Solar System they also receive personalized system design; equipment and connectivity; drawings and permitting with all local jurisdictions; professional installation; and system testing. In addition, they also receive any necessary local government and utility company inspections.

ABCO Energy, Inc. (ABCE), closed Monday's trading session at $0.0062, up 6.90%, on 269,597 volume with 15 trades. The average volume for the last 60 days is 66,660 and the stock's 52-week low/high is $0.0041/$1.667.


The QualityStocks
Company Corner


ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $1.27, up 10.43%, on 132,414 volume with 151 trades. The stock’s average daily volume over the past 60 days is 188,586 and its 52-week low/high is $0.12/$2.75.

ChineseInvestors.com, Inc., was announced today by leading independent small-cap equity research firm SeeThruEquity as having a new coverage update available for investors. SeeThruEquity also upwardly revised its price target for CIIX to $3.75 a share, reflecting potential from the company's legal cannabis initiatives.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com Blog

ChineseInvestors.com News:

SeeThruEquity Issues Update on ChineseInvestors.com Inc. (OTCQB: CIIX), Increasing Price Target to $3.75

ChineseInvestors.com, Inc. to Present at the National Investment Banking Association Conference in New York City on February 28, 2017

ChineseInvestors.com Presents at Yibao Biologics' Annual Conference, Optimistic About Direct Selling Opportunity in China

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0007, even for the day, on 14,282,056 volume with 16 trades. The stock’s average daily volume over the past 60 days is 14,907,411 and its 52-week low/high is $0.0006/$0.028.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Continues Discussions with Madagascar for Energy Projects

Dominovas Energy Secures Gas Supply for South Africa

Dominovas Energy Dispatches Watkins to Meet With Gas Supplier

Stealth Technologies Inc. (STTH)

The QualityStocks Daily Newsletter would like to spotlight Stealth Technologies Inc. (STTH). Today, Stealth Technologies Inc. closed trading at $0.03, up 9.85%, on 15,800 volume with 2 trades. The stock’s average daily volume over the past 60 days is 28,334, and its 52-week low/high is $0.015/$0.05.

Founded in 1999, Stealth Technologies Inc. (STTH) is focused on developing and marketing products that deliver cost effective, independently validated solutions for large addressable international and domestic markets. The company's primary target is identity protection and personal safety.

The Stealth Card represents the company's flagship solution for identity protection. Today there are more than 1.5 billion credit and debit cards in circulation with RFID chips, making it easier than ever for identity thieves to steal sensitive information without contact. The paper-thin Stealth Card offered by Stealth Technologies protects up to 12 RFID credit cards in a wallet without any batteries or charging requirements.

StealthIdentityTheft.com is an expansion of the company's commitment to provide first-rate identity protection solutions. The proprietary system underlying this identity protection and recovery service was designed in partnership with law enforcement officials. Utilizing the most effective methods of prevention involving a two-step process, StealthIdentityTheft.com is a superior answer to the non-stop identity theft taking place every day.

The international marketplace was infiltrated by Stealth Technologies when the company launched its 911 HELP NOW™ emergency medical alert device. Providing direct access with 911 service at a touch of a button, the device is packed with powerful features including a full year of battery life from standard AAA batteries, compact ergonomic design, 2-way voice and a durable, splash resistant design.

Stealth Mobile is the latest product offering introduced to leverage the Stealth Technologies' brand and sales channels established by the other products. Similar to the Stealth Card, Stealth Mobile prevents electronic pickpocketing. The product guards NFC transmissions emitted by cell phone devices, which can include personal information, messages and financial data.

Stealth Technologies recognizes the value of the rapid sales growth generated by these technologies and has multiple patents pending to safeguard its investments. With an expanding product suite and ongoing expansion into the identity theft protection marketplace, Stealth Technologies remains committed to its focus on increased growth and profitability. Disclaimer

Stealth Technologies Inc. Company Blog

Stealth Technologies Inc. News:

Stealth Technologies Announces 5 New Products

Stealth Technologies Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference

NetworkNewsWire Releases Exclusive Audio Interview with Stealth Technologies, Inc. (STTH)

InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.2716, up 0.22%, on 445,803 volume with 217 trades. The stock’s average daily volume over the past 60 days is 809,827, and its 52-week low/high is $0.05/$0.4261.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. News:

InMed Pharmaceuticals Files PCT Patent for Epidermolysis Bullosa Simplex

InMeds Bioinformatics Platform Powers Cannabinoid Drug Development -- CFN Media

InMed Receives over $1,350,000 From Warrant Exercise

Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.50, up 8.70%, on 15,633 volume with 11 trades. The stock’s average daily volume over the past 60 days is 6,713, and its 52-week low/high is $1.33/$4.35.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

Monaker Group to Present at the 29th Annual ROTH Conference, March 15, 2017

Monaker Group Appoints Robert Post to Board of Directors

Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(LMNK) +214.85%


(TGTX) +90.65%


(LLLI) +88.89%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251